Steady state [Regulatives / Guidelines]

posted by kumarnaidu – Mumbai, India, 2014-12-10 12:15 (3844 d 09:13 ago) – Posting: # 14044
Views: 15,022

Hi All,
I am little bit confused with this statement.
In all other cases, where accumulation is likely (AUC(0-τ) after the first dose covers less than 90% of mean AUC(0-∞)) a multiple dose study is required. Generally, steady-state studies should be performed under the conditions concerning concomitant food intake recommended in the SmPC for the originator product.

If for any drug concomittant food intake is reccomended and it shows no accumulation (AUC(0-τ) after the first dose covers less than 90% of mean AUC(0-∞)) then in that case should we go for steady state or not?:confused:

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
18 visitors (0 registered, 18 guests [including 9 identified bots]).
Forum time: 22:29 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5